Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M394Revenue $M3.6Net Margin (%)-165.2Z-Score28.8
Enterprise Value $M285EPS $-0.4Operating Margin %-200.0F-Score5
P/E(ttm))0Cash Flow Per Share $-0.3Pre-tax Margin (%)-159.9Higher ROA y-yY
Price/Book3.810-y EBITDA Growth Rate %-3.8Quick Ratio21.6Cash flow > EarningsN
Price/Sales48.65-y EBITDA Growth Rate %16.0Current Ratio21.6Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-13.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-17.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M48.5ROI % (ttm)-71.8Gross Margin Increase y-yY

Gurus Latest Trades with CGEN

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

CGEN is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


CGEN: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about CGEN :

    Quarterly/Annual Reports about CGEN:

      News about CGEN:

      Articles On GuruFocus.com
      creiter note on CGEN Jan 03 2010 
      Compugen Reports Second Quarter 2009 Results Jul 28 2009 
      Compugen Ltd. Reports Fourth Quarter and Year-End 2008 Financial Results Feb 11 2009 
      Compugen Ltd. to Review Fourth Quarter and Year-End 2008 Financial Results on Wednesday, February 11 Feb 04 2009 

      More From Other Websites
      7:07 am Compugen enters Immuno-Oncology research collaboration with Johns Hopkins University Dec 18 2014
      Compugen Enters Immuno-Oncology Research Collaboration with Johns Hopkins University Dec 18 2014
      Will Compugen (CGEN) Continue to Surge Higher? Dec 10 2014
      Compugen (CGEN) Worth Watching: Stock Moves 8.8% Higher Dec 08 2014
      Compugen to Present at Oppenheimer 25th Annual Healthcare Conference Dec 03 2014
      Compugen to Present at Oppenheimer 25th Annual Healthcare Conference Dec 03 2014
      Compugen Announces Experimental Confirmation of Additional Methodology for Discovery of... Dec 02 2014
      Compugen Announces Experimental Confirmation of Additional Methodology for Discovery of... Dec 02 2014
      Investors' Radars Failed to Catch Compugen (CGEN), Has Yours? Nov 24 2014
      Compugen (CGEN) Worth Watching: Stock Adds 6% in Session Nov 21 2014
      Compugen (CGEN) Enters Oversold Territory Nov 18 2014
      Compugen to Present at Jefferies 2014 Global Healthcare Conference in London Nov 12 2014
      Compugen to Present at Jefferies 2014 Global Healthcare Conference in London Nov 12 2014
      Compugen to Present at Jefferies 2014 Global Healthcare Conference in London Nov 12 2014
      Should Compugen (CGEN) Be On Your Radar Now? Nov 05 2014
      Compugen posts 3Q loss Oct 29 2014
      Compugen posts 3Q loss Oct 29 2014
      Compugen Ltd. Reports Third Quarter 2014 Financial Results Oct 29 2014
      Compugen Ltd. Reports Third Quarter 2014 Financial Results Oct 29 2014
      Compugen Discloses Successful Validation Results for Novel B7/CD28–like Cancer Immunotherapy... Oct 27 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK